FDA Clearance Tracker · K760132
TEST, RIA, TSH QUANTIMUNE
Last checked: Nov 19, 2026Latest source record: Jul 20, 1976 (this decision)Source: openFDAMethods & limitations
Decided
Jul 20, 1976
Substantially Equivalent
Time to decision
22 days
Received Jun 28, 1976. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K760132
- Device name
- TEST, RIA, TSH QUANTIMUNE
- Applicant
- Bio-Rad
- Applicant location
- Mchenry, IL
- Received
- Jun 28, 1976
- Decided
- Jul 20, 1976
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 862.1690
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code JLW (Radioimmunoassay, Thyroid-Stimulating Hormone).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Bio-Rad
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- BioPlex 2200 Lyme Total510(k)
K183446 · Decided Mar 12, 2019 · 90 days after receipt
Device type: Reagent, Borrelia Serological Reagent (LSR) · Laboratory Medicine & Pathology
K181661 · Decided Feb 13, 2019 · 233 days after receipt
Device type: Bcr/Abl1 Monitoring Test (OYX) · Laboratory Medicine & Pathology
K180577 · Decided Jun 22, 2018 · 109 days after receipt
Device type: System, Test, Vitamin D (MRG) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.